22,674 Shares in Medtronic plc. (MDT) Acquired by Sawyer & Company Inc

Sawyer & Company Inc purchased a new stake in shares of Medtronic plc. (NYSE:MDT) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 22,674 shares of the medical technology company’s stock, valued at approximately $1,831,000. Medtronic makes up approximately 1.2% of Sawyer & Company Inc’s portfolio, making the stock its 26th largest holding.

Several other hedge funds have also recently bought and sold shares of MDT. Janus Henderson Group PLC acquired a new stake in Medtronic in the third quarter worth $579,952,000. Lazard Asset Management LLC increased its position in Medtronic by 43.8% in the second quarter. Lazard Asset Management LLC now owns 19,669,866 shares of the medical technology company’s stock worth $1,745,699,000 after buying an additional 5,991,094 shares during the period. Alliancebernstein L.P. increased its position in Medtronic by 135.5% in the second quarter. Alliancebernstein L.P. now owns 6,070,160 shares of the medical technology company’s stock worth $538,727,000 after buying an additional 3,493,058 shares during the period. BlackRock Inc. increased its position in Medtronic by 2.8% in the second quarter. BlackRock Inc. now owns 89,512,229 shares of the medical technology company’s stock worth $7,944,210,000 after buying an additional 2,476,853 shares during the period. Finally, Vanguard Group Inc. increased its position in Medtronic by 2.4% in the second quarter. Vanguard Group Inc. now owns 104,776,036 shares of the medical technology company’s stock worth $9,298,872,000 after buying an additional 2,454,380 shares during the period. 81.75% of the stock is currently owned by institutional investors and hedge funds.

In related news, EVP Hooman Hakami sold 26,158 shares of the firm’s stock in a transaction dated Friday, January 5th. The stock was sold at an average price of $85.00, for a total transaction of $2,223,430.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Bryan C. Hanson sold 16,000 shares of the firm’s stock in a transaction dated Thursday, November 16th. The shares were sold at an average price of $79.02, for a total value of $1,264,320.00. The disclosure for this sale can be found here. Insiders have sold 136,684 shares of company stock valued at $11,582,596 in the last ninety days. Company insiders own 0.31% of the company’s stock.

Several brokerages have weighed in on MDT. Jefferies Group reaffirmed a “buy” rating and issued a $96.00 target price on shares of Medtronic in a research report on Thursday, September 28th. SunTrust Banks reaffirmed a “buy” rating and issued a $96.00 target price on shares of Medtronic in a research report on Monday, October 2nd. Stifel Nicolaus dropped their target price on Medtronic from $91.00 to $83.00 and set a “hold” rating on the stock in a research report on Monday, October 9th. Wells Fargo & Co lowered Medtronic from an “outperform” rating to a “market perform” rating and dropped their target price for the stock from $93.00 to $83.00 in a research report on Monday, October 9th. Finally, Needham & Company LLC dropped their target price on Medtronic from $95.00 to $94.00 and set a “buy” rating on the stock in a research report on Tuesday, October 10th. Two analysts have rated the stock with a sell rating, nine have issued a hold rating and fifteen have given a buy rating to the stock. The stock has an average rating of “Buy” and a consensus price target of $89.65.

Medtronic plc. (MDT) opened at $85.45 on Tuesday. Medtronic plc. has a 52 week low of $73.59 and a 52 week high of $89.72. The stock has a market capitalization of $115,660.00, a price-to-earnings ratio of 23.48, a PEG ratio of 2.35 and a beta of 0.99. The company has a quick ratio of 2.05, a current ratio of 2.40 and a debt-to-equity ratio of 0.50.

Medtronic (NYSE:MDT) last announced its earnings results on Tuesday, November 21st. The medical technology company reported $1.07 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.99 by $0.08. Medtronic had a return on equity of 12.63% and a net margin of 16.93%. The business had revenue of $7.05 billion during the quarter, compared to analysts’ expectations of $7.05 billion. During the same quarter last year, the business posted $1.12 earnings per share. The company’s quarterly revenue was down 4.0% on a year-over-year basis. research analysts expect that Medtronic plc. will post 4.77 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, January 19th. Investors of record on Friday, December 29th will be paid a dividend of $0.46 per share. The ex-dividend date of this dividend is Thursday, December 28th. This represents a $1.84 annualized dividend and a yield of 2.15%. Medtronic’s dividend payout ratio is currently 50.55%.

TRADEMARK VIOLATION NOTICE: This report was first posted by Week Herald and is owned by of Week Herald. If you are reading this report on another site, it was stolen and republished in violation of US & international trademark & copyright law. The original version of this report can be accessed at https://weekherald.com/2018/01/16/22674-shares-in-medtronic-plc-mdt-acquired-by-sawyer-company-inc.html.

About Medtronic

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group.

Institutional Ownership by Quarter for Medtronic (NYSE:MDT)

Receive News & Ratings for Medtronic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply